95 participants
Phase II Study Evaluating Safety and Efficacy of Tislelizumab for Elderly Patients Unfit for Chemotherapy, With Advanced Esophageal Squamous-cell Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-20
- Start Date:
- 2025-10-07
- Completion:
- 2029-10-31
Conditions
- Esophageal Squamous Cell Carcinoma (ESCC)
Interventions
- DRUG
No Results Yet